Keep pulling the thread on Sir David Spiegelhalter.
The serial killer Harold Shipman murdered at least 250, and possibly up to 400, of his patients in the UK over a 20-year period.
The UK government acknowledged that the AstraZeneca COVID-19 vaccine caused rare but serious blood clots, particularly in young people, a risk that was first widely detected in Norway.
Google's DeepMind has achieved impressive results in protein folding and medical diagnostics for breast cancer and eye problems, the latter in collaboration with Moorfields Hospital.
According to Bill Gates, it would cost approximately $1 billion per year to ensure the world is prepared for the next pandemic, a sum that is not currently being spent.
A statistical analysis concluded that serial killer Harold Shipman could have been detected after a few years due to his high number of excess deaths, but no one was monitoring the relevant data at the time.
The statistical process control system developed for the Harold Shipman inquiry has since been adapted to monitor outcomes in children's intensive care units across the UK.
The UK's NHS is currently implementing a new, rigorous statistical monitoring system for adverse events in maternity units following numerous scandals.
A competition is underway in weather forecasting between traditional physics-based models and new AI models, such as those from DeepMind, which use a data-driven, pattern-recognition approach.
The UK Met Office is operating and encouraging collaboration between both traditional physics-based and new AI-based weather forecasting teams.
Clinical trial data for the prostate cancer drug abiraterone shows a median survival of approximately 18 months, though this data is based on older trials with sicker patients.
There is currently a lack of good long-term survival data for patients with earlier-stage oligometastatic prostate cancer treated with newer drugs like abiraterone.
The World Anti-Doping Agency developed an 'athletics passport' to maintain a longitudinal record of an athlete's drug testing history, enabling individualized biological baselines for fairer testing.